# Efficacy of the Use of Cellular Matrix/ A-CP-HA Kit

> **NCT06425978** · PHASE4 · RECRUITING · sponsor: **Fundación Santiago Dexeus Font** · enrollment: 192 (estimated)

## Conditions studied

- Genitourinary Syndrome of Menopause

## Interventions

- **DRUG:** Cellular Matrix / A-CP-HA Kit
- **DRUG:** Local estrogen therapy (Blissel, estriol 50 micrograms/g vaginal gel)

## Key facts

- **NCT ID:** NCT06425978
- **Lead sponsor:** Fundación Santiago Dexeus Font
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-30
- **Primary completion:** 2026-05
- **Final completion:** 2026-08
- **Target enrollment:** 192 (ESTIMATED)
- **Last updated:** 2024-07-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06425978

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06425978, "Efficacy of the Use of Cellular Matrix/ A-CP-HA Kit". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06425978. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*